Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zepp Health (ZEPP) Short term Debt (2016 - 2025)

Historic Short term Debt for Zepp Health (ZEPP) over the last 10 years, with Q3 2025 value amounting to $1.7 million.

  • Zepp Health's Short term Debt fell 4633.01% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 4633.01%. This contributed to the annual value of $2.5 million for FY2024, which is 4656.8% up from last year.
  • According to the latest figures from Q3 2025, Zepp Health's Short term Debt is $1.7 million, which was down 4633.01% from $531000.0 recorded in Q2 2025.
  • Zepp Health's Short term Debt's 5-year high stood at $72.0 million during Q4 2022, with a 5-year trough of $531000.0 in Q2 2025.
  • Over the past 5 years, Zepp Health's median Short term Debt value was $21.1 million (recorded in 2023), while the average stood at $27.8 million.
  • As far as peak fluctuations go, Zepp Health's Short term Debt tumbled by 9768.49% in 2023, and later soared by 4862.16% in 2024.
  • Zepp Health's Short term Debt (Quarter) stood at $56.0 million in 2021, then increased by 28.56% to $72.0 million in 2022, then crashed by 97.68% to $1.7 million in 2023, then skyrocketed by 48.62% to $2.5 million in 2024, then plummeted by 30.04% to $1.7 million in 2025.
  • Its last three reported values are $1.7 million in Q3 2025, $531000.0 for Q2 2025, and $1.0 million during Q1 2025.